Position in ABCL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,764,650
-$2,501,673 QoQ
Shares Held
2,224,829
-25.9% QoQ
Ownership
0.729%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 138 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 92.98332590954182.ToString("F0")%
Shared 0.ToString("F0")%
None 7.016674090458189.ToString("F0")%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. ABCL ranks #157 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in ABCL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,764,650 | 2,224,829 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,266,323 | 3,001,850 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $14,044,472 | 2,792,142 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $3,419,457 | 996,927 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $2,878,964 | 1,291,016 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,746,534 | 937,385 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,533,095 | 589,653 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,634,302 | 552,130 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,767,327 | 390,139 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $2,152,039 | 376,890 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,674,507 | 581,415 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $7,636,659 | 1,182,146 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,856,903 | 909,404 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,437,956 | 635,534 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,952,765 | 703,010 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,101,377 | 479,003 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $3,833,073 | 393,136 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $7,163,868 | 500,970 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,749,818 | 736,019 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $12,632,246 | 574,193 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,457,514 | 72,365 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $118,708 | 2,950 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||